This is a table of adjective/noun combinations and their frequencies from sentences in your study carrel. Use it to search & browse the list to learn more about your study carrel.
adjective | noun | frequency |
---|---|---|
- | cell | 2252 |
peripheral | blood | 1023 |
immune | response | 730 |
- | cells | 623 |
red | blood | 584 |
red | cell | 523 |
median | time | 480 |
immune | responses | 475 |
high | risk | 433 |
- | risk | 383 |
red | cells | 332 |
specific | t | 311 |
- | t | 290 |
- | time | 260 |
- | transfusion | 241 |
- | hla | 225 |
first | time | 175 |
viral | infections | 157 |
high | levels | 137 |
autologous | blood | 132 |
- | year | 124 |
- | peptide | 123 |
specific | antibodies | 122 |
- | transplantation | 115 |
viral | infection | 112 |
higher | risk | 106 |
human | t | 106 |
immune | cells | 106 |
positive | results | 101 |
- | protein | 99 |
positive | cells | 91 |
high | level | 85 |
first | year | 83 |
- | blood | 82 |
- | donor | 80 |
- | group | 77 |
- | treatment | 77 |
low | risk | 75 |
- | antibodies | 71 |
low | levels | 71 |
severe | disease | 70 |
autologous | transplantation | 65 |
immune | cell | 64 |
- | analysis | 64 |
- | infection | 60 |
viral | proteins | 60 |
- | antigen | 55 |
negative | blood | 55 |
higher | levels | 53 |
other | studies | 52 |
single | donor | 49 |
overall | response | 48 |
positive | donors | 48 |
post | transfusion | 47 |
median | day | 47 |
- | disease | 46 |
clinical | studies | 46 |
positive | antibody | 46 |
positive | result | 46 |
significant | antibodies | 46 |
different | hla | 45 |
significant | risk | 45 |
low | level | 44 |
positive | patients | 44 |
clinical | response | 43 |
other | groups | 43 |
- | day | 43 |
- | patient | 43 |
severe | patients | 42 |
specific | antibody | 42 |
- | level | 41 |
different | time | 40 |
negative | results | 40 |
other | patients | 40 |
other | blood | 39 |
post | transplantation | 39 |
single | cell | 38 |
- | patients | 37 |
- | platelet | 37 |
human | platelet | 37 |
more | patients | 37 |
specific | hla | 37 |
- | p | 36 |
human | cells | 36 |
viral | antigens | 35 |
first | day | 35 |
peripheral | t | 35 |
- | donors | 34 |
different | blood | 34 |
new | donors | 34 |
- | antibody | 34 |
different | cell | 33 |
lower | levels | 32 |
other | diseases | 32 |
negative | patients | 31 |
positive | blood | 31 |
- | antigens | 31 |
other | patient | 30 |
severe | infections | 30 |
viral | peptides | 30 |
human | hla | 29 |
- | response | 28 |
acute | infection | 28 |
new | blood | 28 |
- | peptides | 27 |
specific | antigens | 27 |
lower | risk | 26 |
autologous | donors | 25 |
different | methods | 25 |
specific | antigen | 25 |
different | levels | 24 |
human | blood | 24 |
first | study | 23 |
negative | result | 23 |
other | cell | 23 |
such | patients | 23 |
first | patient | 22 |
clinical | study | 22 |
different | t | 21 |
negative | donors | 21 |
first | transfusion | 20 |
median | days | 20 |
specific | treatment | 20 |
different | peptides | 19 |
important | risk | 18 |
new | method | 18 |
severe | infection | 17 |
positive | donor | 17 |
chronic | disease | 17 |
different | donors | 16 |
different | groups | 16 |
low | blood | 16 |
other | cells | 16 |
other | day | 16 |
severe | transfusion | 16 |
viral | antigen | 16 |
- | groups | 16 |
other | donors | 15 |
such | studies | 15 |
single | antigen | 15 |
- | years | 15 |
other | antigens | 15 |
negative | group | 15 |
viral | protein | 14 |
other | hla | 14 |
other | methods | 14 |
single | peptide | 14 |
first | blood | 14 |
clinical | transfusion | 14 |
clinical | results | 14 |
viral | diseases | 13 |
specific | responses | 13 |
specific | peptide | 13 |
specific | blood | 13 |
post | infection | 13 |
other | infections | 13 |
median | patient | 13 |
human | disease | 13 |
higher | response | 13 |
high | blood | 13 |
first | results | 13 |
first | group | 13 |
different | donor | 13 |
autologous | t | 13 |
other | t | 12 |
viral | peptide | 12 |
specific | cells | 12 |
specific | cell | 12 |
other | proteins | 12 |
- | analyses | 12 |
immune | antibodies | 12 |
highest | risk | 12 |
chronic | infection | 12 |
negative | cells | 12 |
new | treatment | 11 |
single | hla | 11 |
positive | t | 11 |
other | antibodies | 11 |
positive | group | 11 |
more | days | 11 |
human | proteins | 11 |
human | platelets | 11 |
different | patient | 11 |
human | cell | 10 |
viral | disease | 10 |
such | cells | 10 |
post | treatment | 10 |
other | treatment | 10 |
other | risk | 10 |
negative | antibody | 10 |
more | time | 10 |
median | platelet | 10 |
high | t | 10 |
highest | level | 10 |
higher | platelet | 10 |
high | response | 10 |
different | treatment | 10 |
clinical | risk | 10 |
clinical | disease | 10 |
anti | hla | 10 |
- | platelets | 10 |
different | times | 9 |
specific | response | 9 |
significant | antigens | 9 |
new | t | 9 |
new | donor | 9 |
median | cell | 9 |
low | platelet | 9 |
first | days | 9 |
different | peptide | 9 |
different | proteins | 9 |
different | antigens | 9 |
clinical | transplantation | 9 |
clinical | responses | 9 |
chronic | infections | 9 |
autologous | patients | 9 |
- | methods | 9 |
high | platelet | 8 |
specific | peptides | 8 |
single | t | 8 |
other | treatments | 8 |
other | donor | 8 |
new | methods | 8 |
negative | t | 8 |
human | studies | 8 |
negative | donor | 8 |
high | disease | 8 |
- | responses | 8 |
high | cell | 8 |
high | antibody | 8 |
chronic | antibody | 8 |
autologous | transplantations | 8 |
autologous | platelet | 8 |
- | study | 8 |
more | hla | 7 |
more | studies | 7 |
other | group | 7 |
positive | patient | 7 |
single | patient | 7 |
positive | response | 7 |
significant | levels | 7 |
single | blood | 7 |
median | disease | 7 |
such | antibodies | 7 |
more | donors | 7 |
positive | platelets | 7 |
low | t | 7 |
first | analysis | 7 |
- | levels | 7 |
autologous | transfusion | 7 |
chronic | transfusion | 7 |
different | diseases | 7 |
different | studies | 7 |
more | donor | 7 |
high | donor | 7 |
higher | level | 7 |
human | protein | 7 |
immune | diseases | 7 |
higher | cell | 7 |
significant | response | 6 |
new | risk | 6 |
other | risks | 6 |
overall | results | 6 |
positive | cell | 6 |
severe | patient | 6 |
specific | risk | 6 |
specific | protein | 6 |
specific | proteins | 6 |
new | antibodies | 6 |
such | diseases | 6 |
such | transfusions | 6 |
viral | response | 6 |
new | platelet | 6 |
specific | risks | 6 |
median | level | 6 |
different | patients | 6 |
median | blood | 6 |
- | studied | 6 |
autologous | cells | 6 |
chronic | transfusions | 6 |
clinical | patients | 6 |
different | cells | 6 |
chronic | diseases | 6 |
different | response | 6 |
low | hla | 6 |
human | diseases | 6 |
important | blood | 6 |
important | treatment | 6 |
high | hla | 6 |
significant | blood | 5 |
median | times | 5 |
more | years | 5 |
other | peptides | 5 |
overall | disease | 5 |
significant | t | 5 |
significant | platelet | 5 |
single | antibody | 5 |
single | donors | 5 |
median | donor | 5 |
specific | group | 5 |
median | levels | 5 |
low | antibody | 5 |
lower | level | 5 |
first | years | 5 |
lower | cell | 5 |
autologous | group | 5 |
different | disease | 5 |
different | results | 5 |
acute | blood | 5 |
high | treatment | 5 |
higher | antibody | 5 |
higher | donor | 5 |
higher | risks | 5 |
human | infection | 5 |
new | antibody | 4 |
new | antigens | 4 |
new | hla | 4 |
new | level | 4 |
other | disease | 4 |
other | platelet | 4 |
other | transfusion | 4 |
overall | blood | 4 |
overall | risk | 4 |
positive | disease | 4 |
positive | peptide | 4 |
more | peptide | 4 |
severe | blood | 4 |
significant | transfusion | 4 |
single | protein | 4 |
specific | disease | 4 |
specific | groups | 4 |
specific | results | 4 |
such | antigen | 4 |
such | donors | 4 |
such | treatment | 4 |
viral | antibodies | 4 |
viral | risk | 4 |
more | transfusions | 4 |
positive | groups | 4 |
more | infections | 4 |
different | platelet | 4 |
- | infections | 4 |
- | proteins | 4 |
- | times | 4 |
acute | disease | 4 |
acute | infections | 4 |
acute | response | 4 |
chronic | blood | 4 |
chronic | platelet | 4 |
clinical | treatment | 4 |
different | group | 4 |
more | antigens | 4 |
different | risk | 4 |
high | group | 4 |
high | groups | 4 |
high | transfusion | 4 |
human | antibodies | 4 |
human | donors | 4 |
low | cells | 4 |
lower | t | 4 |
median | platelets | 4 |
median | treatment | 4 |
first | result | 4 |
others | donors | 3 |
positive | transfusions | 3 |
peripheral | cells | 3 |
overall | responses | 3 |
overall | p | 3 |
negative | studied | 3 |
non | t | 3 |
new | peptide | 3 |
new | disease | 3 |
new | cell | 3 |
significant | infections | 3 |
significant | antibody | 3 |
single | risk | 3 |
significant | results | 3 |
single | disease | 3 |
single | methods | 3 |
single | platelet | 3 |
single | treatment | 3 |
specific | transfusion | 3 |
such | peptides | 3 |
such | proteins | 3 |
such | response | 3 |
viral | risks | 3 |
more | blood | 3 |
more | t | 3 |
severe | t | 3 |
median | years | 3 |
human | donor | 3 |
median | year | 3 |
- | treatments | 3 |
chronic | patients | 3 |
clinical | analysis | 3 |
clinical | blood | 3 |
clinical | methods | 3 |
different | protein | 3 |
different | treatments | 3 |
first | t | 3 |
first | transplantation | 3 |
highest | levels | 3 |
human | antibody | 3 |
autologous | cell | 3 |
human | infections | 3 |
low | group | 3 |
median | response | 3 |
median | % | 3 |
lower | disease | 3 |
lower | blood | 3 |
median | patients | 3 |
low | disease | 3 |
low | cell | 3 |
important | antigen | 3 |
immune | platelet | 3 |
significant | cell | 2 |
severe | response | 2 |
severe | groups | 2 |
severe | diseases | 2 |
post | t | 2 |
positive | transfusion | 2 |
positive | responses | 2 |
positive | platelet | 2 |
positive | peptides | 2 |
positive | hla | 2 |
positive | antigen | 2 |
new | transfusion | 2 |
overall | hla | 2 |
other | study | 2 |
other | protein | 2 |
other | antigen | 2 |
negative | response | 2 |
new | protein | 2 |
new | peptides | 2 |
new | patients | 2 |
new | patient | 2 |
new | antigen | 2 |
significant | hla | 2 |
significant | disease | 2 |
single | time | 2 |
significant | infection | 2 |
significant | level | 2 |
negative | cell | 2 |
viral | responses | 2 |
viral | cell | 2 |
such | study | 2 |
such | blood | 2 |
such | analysis | 2 |
specific | studies | 2 |
specific | patients | 2 |
specific | donor | 2 |
specific | analyses | 2 |
single | transplantation | 2 |
single | study | 2 |
single | peptides | 2 |
single | group | 2 |
single | day | 2 |
single | cells | 2 |
significant | treatment | 2 |
significant | responses | 2 |
significant | protein | 2 |
significant | peptides | 2 |
significant | p | 2 |
negative | patient | 2 |
new | studies | 2 |
negative | antigens | 2 |
different | transplantation | 2 |
human | antigen | 2 |
highest | cell | 2 |
higher | treatment | 2 |
higher | t | 2 |
higher | disease | 2 |
higher | % | 2 |
high | cells | 2 |
first | treatment | 2 |
first | donor | 2 |
first | cells | 2 |
different | study | 2 |
human | study | 2 |
different | days | 2 |
different | antibodies | 2 |
different | analyses | 2 |
clinical | platelet | 2 |
clinical | groups | 2 |
autologous | peptides | 2 |
autologous | antigen | 2 |
acute | patients | 2 |
acute | cell | 2 |
more | times | 2 |
human | responses | 2 |
acute | transfusion | 2 |
immune | donors | 2 |
lower | transfusion | 2 |
immune | proteins | 2 |
more | results | 2 |
more | methods | 2 |
more | groups | 2 |
more | disease | 2 |
more | cells | 2 |
more | antibodies | 2 |
median | group | 2 |
lowest | risk | 2 |
more | platelet | 2 |
lower | response | 2 |
low | patients | 2 |
important | antigens | 2 |
lower | hla | 2 |
important | studies | 2 |
important | cell | 2 |
more | risk | 2 |
lower | % | 2 |
lower | antibody | 2 |
low | response | 2 |
lower | day | 2 |
overall | day | 1 |
other | method | 1 |
other | peptide | 1 |
other | responses | 1 |
other | studied | 1 |
other | time | 1 |
other | transplantation | 1 |
others | diseases | 1 |
others | infections | 1 |
others | t | 1 |
positive | antibodies | 1 |
overall | group | 1 |
overall | methods | 1 |
overall | platelet | 1 |
overall | result | 1 |
overall | t | 1 |
overall | time | 1 |
overall | transfusion | 1 |
peripheral | antibody | 1 |
other | levels | 1 |
peripheral | antigen | 1 |
overall | infections | 1 |
new | group | 1 |
non | response | 1 |
non | hla | 1 |
more | treatment | 1 |
positive | risk | 1 |
negative | antigen | 1 |
negative | disease | 1 |
negative | groups | 1 |
negative | infections | 1 |
negative | peptide | 1 |
negative | platelet | 1 |
negative | platelets | 1 |
negative | responses | 1 |
new | cells | 1 |
new | diseases | 1 |
new | platelets | 1 |
new | proteins | 1 |
new | risks | 1 |
new | study | 1 |
new | treatments | 1 |
newer | methods | 1 |
non | blood | 1 |
positive | infection | 1 |
specific | patient | 1 |
positive | treatment | 1 |
such | results | 1 |
specific | transplantation | 1 |
specific | year | 1 |
such | antigens | 1 |
such | group | 1 |
such | infection | 1 |
such | infections | 1 |
such | method | 1 |
such | peptide | 1 |
such | responses | 1 |
such | transfusion | 1 |
post | antibody | 1 |
such | transplantation | 1 |
such | transplantations | 1 |
viral | antibody | 1 |
viral | hla | 1 |
viral | method | 1 |
viral | results | 1 |
viral | t | 1 |
viral | transfusion | 1 |
more | transfusion | 1 |
specific | platelet | 1 |
specific | methods | 1 |
specific | level | 1 |
specific | infections | 1 |
post | cell | 1 |
post | donor | 1 |
post | hla | 1 |
post | platelet | 1 |
severe | group | 1 |
severe | studies | 1 |
significant | group | 1 |
significant | peptide | 1 |
significant | proteins | 1 |
significant | time | 1 |
single | infection | 1 |
single | method | 1 |
single | patients | 1 |
single | platelets | 1 |
single | proteins | 1 |
single | transfusion | 1 |
specific | analysis | 1 |
specific | day | 1 |
specific | diseases | 1 |
more | transplantation | 1 |
- | studies | 1 |
more | risks | 1 |
high | peptide | 1 |
first | antibody | 1 |
first | cell | 1 |
first | infection | 1 |
first | level | 1 |
first | protein | 1 |
first | response | 1 |
first | resulted | 1 |
first | studied | 1 |
high | % | 1 |
high | platelets | 1 |
highest | blood | 1 |
high | protein | 1 |
high | risks | 1 |
high | transplantation | 1 |
higher | blood | 1 |
higher | day | 1 |
higher | infection | 1 |
higher | patient | 1 |
higher | peptide | 1 |
higher | protein | 1 |
different | transfusion | 1 |
different | infections | 1 |
different | antigen | 1 |
different | antibody | 1 |
- | days | 1 |
- | diseased | 1 |
- | grouping | 1 |
- | method | 1 |
- | result | 1 |
- | timed | 1 |
- | transplantations | 1 |
acute | platelet | 1 |
acute | t | 1 |
acute | treatment | 1 |
anti | t | 1 |
autologous | antigens | 1 |
autologous | donor | 1 |
autologous | patient | 1 |
chronic | t | 1 |
chronic | treatment | 1 |
clinical | group | 1 |
clinical | infections | 1 |
clinical | level | 1 |
higher | transplantation | 1 |
highest | hla | 1 |
more | proteins | 1 |
lowest | level | 1 |
low | groups | 1 |
low | responses | 1 |
low | results | 1 |
low | transplantation | 1 |
low | treatment | 1 |
lower | infection | 1 |
lower | p | 1 |
lower | platelet | 1 |
lower | results | 1 |
lowest | platelet | 1 |
highest | platelet | 1 |
median | antibody | 1 |
median | cells | 1 |
median | result | 1 |
median | risk | 1 |
median | t | 1 |
median | transplantation | 1 |
more | antibody | 1 |
more | cell | 1 |
more | peptides | 1 |
low | donor | 1 |
low | antigen | 1 |
important | transfusion | 1 |
important | t | 1 |
highest | response | 1 |
highest | t | 1 |
highest | time | 1 |
human | antigens | 1 |
human | group | 1 |
human | p | 1 |
human | patient | 1 |
human | patients | 1 |
human | peptide | 1 |
human | peptides | 1 |
immune | disease | 1 |
immune | responsing | 1 |
important | cells | 1 |
important | day | 1 |
important | diseases | 1 |
important | hla | 1 |
important | level | 1 |
important | peptides | 1 |
important | protein | 1 |
viral | treatment | 1 |